Evidence map›Paper›PMID 35199907›Full record

ArticleAging cell2022

Scavenging mitochondrial hydrogen peroxide by peroxiredoxin 3 overexpression attenuates contractile dysfunction and muscle atrophy in a murine model of accelerated sarcopenia.

Bumsoo Ahn, Rojina Ranjit, Parker Kneis, Hongyang Xu, Katarzyna M Piekarz, Willard M Freeman, Michael Kinter, Arlan Richardson, Qitao Ran, Susan V Brooks and 1 more

Open access · goldAbstract read
In one paragraph

Article in Aging cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. iPLAScience advances · 2026
    Article
  6. Article
  7. Article
  8. Deuterated Polyunsaturated Fatty Acids AlleviatebioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Reactive oxygen species in the pathogenesis of sarcopenia.Free radical biology & medicine · 2025
    Review
  14. The link between Mitochondria and Sarcopenia.Journal of physiology and biochemistry · 2025
    Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Decoding the decline: unveiling drivers of sarcopenia.The Journal of clinical investigation · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Bumsoo AhnAging & Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.ORCID 0000-0002-2743-7099
Rojina RanjitAging & Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Parker KneisAging & Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Hongyang XuAging & Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Katarzyna M PiekarzAging & Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.ORCID 0000-0003-4710-9970
Willard M FreemanGenes and Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.ORCID 0000-0001-7027-999X
Michael KinterAging & Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Arlan RichardsonOklahoma Nathan Shock Center for Aging, Oklahoma City, Oklahoma, USA.
Qitao RanDepartment of Cell Systems & Anatomy, UT Health San Antonio, San Antonio, Texas, USA.ORCID 0000-0002-2127-8349
Susan V BrooksDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan, USA.
Holly Van RemmenAging & Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.ORCID 0000-0003-0883-0642
Oklahoma Medical Research Foundation · USOklahoma City University · USThe University of Texas Health Science Center at San Antonio · USUniversity of Michigan · US

Funding

Targeted DNA Methylation and Mitochondrial Heteroplasmy CoreP30AG050911 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Veronica Galvan, Benjamin Francis Miller · 2015 to 2026
$13.9M
TRANSGENIC ANIMAL CORE SUBCONTRACT WITH UTHSC AT SAN ANTONIOP01AG020591 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI BROOKS, SUSAN V · 2002 to 2014
$10.7M
PROJECT 3: Neuromuscular redox homeostasis in mice lacking SOD1 and aging wild type mice subcontract at University of LiverpoolP01AG051442 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BROOKS, SUSAN V · 2016 to 2020
$8.9M
Defining the relative roles of pre- and post-synaptic events in the initiation and progression of sarcopeniaR01AG050676 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BROOKS, SUSAN V, VAN REMMEN, HOLLY · 2016 to 2020
$3.3M
The role of unacylated ghrelin on age-associated progressive muscle weakness and cachexia elicited by cancerR00AG064143 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI AHN, BUMSOO · 2022 to 2024
$839k
The role of unacylated ghrelin on age-associated progressive muscle weakness and cachexia elicited by cancerK99AG064143 · NIA · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI AHN, BUMSOO · 2020 to 2021
$192k
BLR&D Research Career Scientist Award ApplicationIK6BX005238 · VA · OKLAHOMA CITY VA MEDICAL CENTER · PI ARLAN G. RICHARDSON · 2020 to 2026
–
BLR&D Research Career Scientist Award ApplicationIK6BX005234 · VA · OKLAHOMA CITY VA MEDICAL CENTER · PI VAN REMMEN, HOLLY · 2020 to 2024
–
BLRD VA IK6 BX005234BLRD VA IK6 BX005238NIA NIH HHS K99 AG064143NIA NIH HHS P01 AG020591NIA NIH HHS P01 AG051442NIA NIH HHS P30 AG050911NIA NIH HHS R00 AG064143NIA NIH HHS R01 AG050676
6 · The paper itself

Abstract

Age-related muscle atrophy and weakness, or sarcopenia, are significant contributors to compromised health and quality of life in the elderly. While the mechanisms driving this pathology are not fully defined, reactive oxygen species, neuromuscular junction (NMJ) disruption, and loss of innervation are important risk factors. The goal of this study is to determine the impact of mitochondrial hydrogen peroxide on neurogenic atrophy and contractile dysfunction. Mice with muscle-specific overexpression of the mitochondrial H

Indexed as

SarcopeniaAgingAnimalsDisease Models, AnimalHydrogen PeroxideMiceMitochondriaMuscle, SkeletalMuscular AtrophyOxidative StressPeroxiredoxin IIIQuality of LifeSuperoxide Dismutase-1Hydrogen PeroxidePeroxiredoxin IIISuperoxide Dismutase-1aginghydrogen peroxidemitochondriaperoxiredoxin3sarcopenia

Identifiers

PMID35199907
PMCPMC8920438
OpenAlexW4213424565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.